Data Integrity Practices Sample Clauses

The Data Integrity Practices clause establishes requirements for maintaining the accuracy, consistency, and reliability of data handled under the agreement. It typically obligates parties to implement safeguards such as regular data validation, secure storage, and controlled access to prevent unauthorized alterations or data corruption. By setting these standards, the clause helps ensure that all data exchanged or processed remains trustworthy and usable, thereby reducing the risk of errors, fraud, or operational disruptions.
Data Integrity Practices. All activities conducted under the Transition Plan will be conducted in accordance with the following practices: (a) data will be generated using sound scientific techniques and processes; (b) data will be accurately recorded by the persons performing the applicable Technical Transition Services in accordance with data integrity practices; (c) data will be analyzed appropriately without bias in accordance with data integrity practices; (d) data and results from experiments will be stored securely such that it can be retrieved without undue burden; and (e) data trails will exist to demonstrate or reconstruct without undue burden key decisions made during the performance of, presentations made about, and conclusions reached with respect to the activities undertaken in the performance of the Transition Plan. GSK may request changes to the requirements set forth above in this Section 3.5 where GSK reasonably believes such changes are required to ensure that such activities are undertaken in compliance with data integrity practices, and Surface shall use reasonable efforts to accommodate such changes. GSK shall be permitted, in its sole discretion and sole cost and expense, no more than once per Calendar Year, to undertake on-site compliance audits of Surface’s data integrity practices in respect of the activities performed by Surface under the Transition Plan by providing Surface with [***] written notice of GSK’s intent to do so, such audits to be conducted at a time mutually convenient to both Parties. All information revealed to GSK in such audit shall be considered Confidential Information of Surface.
View SourceView Similar (3)
Data Integrity Practices. (a) Each Party and its respective Affiliates shall, and shall require its and their respective Sublicensees and Third Party subcontractors to, conduct all Shared Global Development Activities, including any Clinical Trials under the Joint Development Plan, in accordance with the following practices: (1) Data will be generated using sound scientific techniques and processes and ALCOA principles (A - attributable to the person generating the data; L – legible and permanent; C – contemporaneously recorded; O – original record (or ‘true copy’); A – accurate) and CCEA (C – complete; C – consistent; E – enduring; A – available); (2) Data will be accurately recorded by the Persons performing the applicable Development activities in accordance with data integrity practices; (3) Data will be analyzed appropriately without bias in accordance with data integrity practices; (4) Data and results from experiments and clinical studies will be stored securely such that it can be easily retrieved; and (5) Data trails will exist to easily demonstrate or reconstruct key decisions made during the performance of all activities under the Joint Development Plan, presentations made about such activities, and conclusions reached with respect to the activities undertaken in the performance of the Joint Development Plan. (b) GSK may request reasonable changes to the requirements set forth above in this Section 5.2.8 (Data Integrity Practices) where GSK reasonably believes such changes are required to ensure that such activities are undertaken in compliance with Applicable Law and GSK’s written standards applicable to GSK’s contracts with Persons conducting Development activities with or for GSK, including activities funded in whole or in part by GSK. ▇▇▇▇▇▇▇ ▇▇▇▇▇ [**] as soon as reasonably practicable following receipt of GSK’s written request. GSK shall be permitted, in its sole discretion and at its sole cost and expense, to undertake on-site compliance audits of Mersana’s data integrity practices in respect of the Shared Global Development Activities performed by ▇▇▇▇▇▇▇ to inspect ▇▇▇▇▇▇▇’s compliance with the terms of this Section 5.2.8 (Data Integrity Practices) by providing Mersana with [**] written notice of GSK’s intent to do so, such audits to be conducted at a time agreed by the Parties and no more frequently than once every [**] during the Term.
View Source

Related to Data Integrity Practices

  • Security Practices Dell has implemented corporate information security practices and standards that are designed to safeguard the Dell’s corporate environment and to address: (1) information security; (2) system and asset management; (3) development; and (4) governance. These practices and standards are approved by the Dell CIO and undergo a formal review on an annual basis.

  • SAFETY PRACTICES (a) i Employees requiring glasses must wear glasses, preferably with safety lenses instead of contact lenses while on the job site. ii W.C.B. approved safety footwear must be worn at all times while on the job site. iii Employee attire will be in conformance with W.C.B. Regulation and the Employer’s policy.

  • Data Practices Supplier and Sourcewell acknowledge Sourcewell is subject to the Minnesota Government Data Practices Act, Minnesota Statutes Chapter 13. As it applies to all data created and maintained in performance of this Agreement, Supplier may be subject to the requirements of this chapter.

  • Data Integrity Policies and procedures to ensure the confidentiality, integrity, and availability of Customer Data or Professional Services Data and protect it from disclosure, improper alteration, or destruction.

  • Pay Practices The Employer recognizes the importance of regularity in pay practices and to the greatest extent possible the Employer will not alter the payment routines. Nurses will be notified in writing by the Employer not less than sixty (60) days in advance of a change to the pay practices.